http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Loss of SMARCB1 evokes targetable epigenetic vulnerabilities in epithelioid sarcoma.
Jin, J. X. (First author)DKFZ* ; Fuchslocher, F.DKFZ* ; Carreno-Gonzalez, M.DKFZ* ; Zahnow, F.DKFZ* ; Ceranski, A. K.DKFZ* ; Will, R.DKFZ* ; Helm, D.DKFZ* ; Bestvater, F.DKFZ* ; Banito, A.DKFZ* ; Imle, R.DKFZ* ; Ohmura, S.DKFZ* ; Cidre-Aranaz, F.DKFZ* ; Grünewald, T. (Last author)DKFZ*
2025
Wiley
Hoboken, NJ
This record in other databases:

Please use a persistent id in citations: doi:10.1002/cac2.12665
Note: #EA:B410#LA:B410# / 2025 May;45(5):494-499
Contributing Institute(s):
- Translationale Pädiatrische Sarkomforschung (B410)
- DKTK HD zentral (HD01)
- Zelluläre Tools (W111)
- Proteomics (W120)
- Lichtmikroskopie (W210)
- NWG Weichteilsarkome (B380)
Research Program(s):
- 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)
Appears in the scientific report
2025
Database coverage:
;

;

;

; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection